Noninvasive positive-pressure ventilation in patients with malignancy

Area of Science:

• Pulmonology
• Oncology
• Critical Care Medicine

Background:

• Noninvasive positive-pressure ventilation (NIPPV) is a standard treatment for acute respiratory failure.
• Historically, NIPPV has been underutilized in cancer patient management.
• Emerging evidence suggests NIPPV's utility in select oncologic populations.

Purpose of the Study:

• To evaluate the role and indications of NIPPV in patients with malignancy and acute respiratory failure.
• To define specific patient subgroups within oncology who may benefit from NIPPV.
• To outline criteria for initiating and withholding NIPPV in cancer patients.

Main Methods:

• Review of current literature and clinical guidelines on NIPPV use in cancer patients.
• Analysis of patient subgroups, including hematologic malignancies and those with do-not-intubate status.
• Identification of clinical parameters guiding NIPPV initiation versus conventional mechanical ventilation.

Main Results:

• NIPPV is the preferred initial ventilatory support for acute respiratory failure in patients with hematologic malignancies or post-bone marrow transplantation.
• Early NIPPV initiation is recommended; however, severe distress or altered mental status necessitates conventional mechanical ventilation.
• NIPPV can be considered for select cancer patients with respiratory failure and a do-not-intubate order, and in rare cases of intractable dyspnea in advanced cancer.

Conclusions:

• NIPPV is a valuable tool for managing acute respiratory failure in specific cancer patient populations.
• Careful patient selection and timely initiation are key to successful NIPPV implementation in oncology.
• NIPPV should not be employed solely for life prolongation in terminal respiratory failure.